Obesity Clinical Trial
Official title:
Testing Product Messages in Colombia
NCT number | NCT05783726 |
Other study ID # | 20-0401b |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 12, 2023 |
Est. completion date | June 22, 2023 |
Verified date | May 2023 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Purpose: To better understand the impact of different front-of-package labels (FOPLs) on consumer purchasing intentions and ability to identify unhealthy foods. Participants: ~8,000 Colombians, recruited from Offerwise, that are 18 years or older. Procedures (methods): Participants will be randomly assigned to view images of food and drink products with either a nutrient warning label, Guideline Daily Amount label, Nutriscore label, or no-label control. They will be asked a series of questions about the products and the labels (excluding control group) on them. Questions will also include standard demographic and health related variables.
Status | Completed |
Enrollment | 8086 |
Est. completion date | June 22, 2023 |
Est. primary completion date | June 22, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - 18-64 years old - Resident of Colombia - Offerwise panel member (recruitment platform) Exclusion Criteria: - <18 years old or >64 years old - Not a resident of Colombia |
Country | Name | City | State |
---|---|---|---|
United States | UNC Carolina Population Center | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | The Bloomberg Family Foundation, Inc., Universidad Nacional de Colombia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Selection of Product Higher in Sugar | Percentage of participants who select the less healthy product in a set of two products as the product the consumer most wants to buy. | During ~15 minute online survey | |
Primary | Correct Identification of the Product Higher in Sugar | Percentage of participants who correctly select the product higher in sugar (between two products) | During ~15 minute online survey | |
Secondary | Perceived Message Effectiveness | Perceived message effectiveness of the study labels. Response options are on a 1 to 5 scale, with lower scores representing a higher amount of the construct.
Perceived message effectiveness is measured using 3 items adapted from Baig et al. (2018): concern, unpleasantness, and discouragement. Responses to the 3 items will be averaged to create a perceived message effectiveness score. Question: How much does this message... make you concerned about the health effect of consuming an unhealthy product? discourage you from wanting to eat an unhealthy product? make eating an unhealthy product seem unpleasant to you? Only asked of the label arms, not control. |
During ~15 minute online survey | |
Secondary | Purchase Likelihood | Likelihood that participants would purchase this product in the next week if it were available. Response options are on a 1 to 5 scale, with lower scores representing a higher amount of the construct | During ~15 minute online survey | |
Secondary | Identify Less Healthy Product | Percentage of participants that correctly identify the less healthy product when selecting between two products. | During ~15 minute online survey | |
Secondary | Ability to Identify Product as Having Excess of Sugar/Saturated Fat/Sodium | Percentage of participants who correctly identify that the product contains excess sugar, saturated fat, or sodium. | During ~15 minute online survey | |
Secondary | Most Discouraging Label | Percentage of participants selecting each nutrient label as most discouraging them from consuming the product. | During ~15 minute online survey |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |